A comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine

被引:0
|
作者
Gianfrancesco, FD
Wang, RH
White, RE
Yu, E
机构
[1] HECON Assoc Inc, Montgomery Village, MD USA
[2] AstraZeneca Pharmaceut, Wilmington, DE USA
关键词
D O I
10.1016/S1098-3015(10)64232-5
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:353 / 354
页数:2
相关论文
共 50 条
  • [1] Mental health cost comparison among patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine in a managed care setting: a propensity-matched cohort study
    Meletiche, DM
    Gutierrez, B
    Rupnow, MFT
    Blount, A
    Boccuzzi, S
    [J]. BIPOLAR DISORDERS, 2005, 7 : 77 - 77
  • [2] Mental health cost comparison among patients with bipolar disorder treated with risperidone versus olanzapine or quetiapine in a managed care setting: A propensity-matched cohort study
    Gutierrez, B
    Meletiche, D
    Rupnow, MF
    Blount, A
    Boccuzzi, SJ
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 387 - 387
  • [3] Olanzapine Versus Risperidone Treated Patients In A Bipolar Disorder Observational Study
    Novick, Diego
    Reed, Catherine
    Gonzalez-Pinto, Ana
    Perrin, Elena
    Tohen, Mauricio
    Aguado, Jaume
    Maria Haro, Josep
    [J]. BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 133S - 134S
  • [4] Adjunctive risperidone, olanzapine and quetiapine for the treatment of hospitalized patients with bipolar I disorder: A retrospective study
    Pae, Chi-Un
    Ghaemi, S. Nassir
    Patkar, Ashwin
    Chae, Jeong-Ho
    Bahk, Won-Myong
    Jun, Tae-Youn
    Masand, Prakash
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (07): : 1322 - 1325
  • [5] Comparison of quetiapine, olanzapine, and risperidone in schizophrenia
    Sacchetti, E
    Valsecchi, P
    Regini, C
    Galluzzo, A
    Cacciani, P
    Agrimi, E
    Mencacci, C
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S286 - S286
  • [6] The comparison of risperidone, olanzapine and quetiapine in the treatment of chronic schizophrenia and schizoaffective disorder
    Kim, JG
    Cho, DH
    Choi, HK
    Kim, HJ
    Cho, JH
    Kang, SH
    Lee, SJ
    Lee, JG
    Kim, HT
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S245 - S245
  • [7] A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder
    Guille, C
    Sachs, GS
    Ghaemi, SN
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (09) : 638 - 642
  • [8] Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder
    Kozicky, Jan-Marie
    Torres, Ivan J.
    Bond, David J.
    Lam, Raymond W.
    Yatham, Lakshmi N.
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (02) : 91 - 99
  • [9] Comparison of quetiapine ('Seroquel'), olanzapine, and risperidone in a randomized study in patients with schizophrenia
    Sacchetti, E
    Valseechi, P
    Regini, C
    Galluzzo, A
    Cacciani, P
    Agrimi, E
    Mencacci, C
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S413 - S413
  • [10] COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS AS TREATMENT FOR PATIENTS WITH BIPOLAR DISORDER (EPISODES OF MANIA): A COMPARISON BETWEEN QUETIAPINE, ARIPIPRAZOLE, OLANZAPINE, RISPERIDONE AND ZIPRASIDONE IN THE RUSSIAN HEALTH CARE
    Kulikov, A.
    Komarov, I
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A61 - A62